The Organoid Model Construction Service ecosystem spans upstream material sourcing, midstream technology integration, and downstream delivery to research and development users. Upstream participants supply biocompatible matrices, growth factors, and specialized reagents that enable three‑dimensional cell culture. Midstream actors—platform technology providers, contract research organizations, and system integrators—assemble these inputs into reproducible organoid constructs, embed automation, and apply quality‑control protocols. Downstream, channel partners and scientific distributors convey the finished service to end‑user researchers in academia, pharma, and biotech. Value is created when raw inputs are transformed into biologically relevant models that reduce experimental timelines, and captured through service fees, data licensing, and downstream collaborations.